Invesco Ltd. - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 109 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,739,414
-25.5%
136,561
+4.8%
0.00%0.0%
Q2 2023$3,675,198
+733.6%
130,280
+408.3%
0.00%
Q1 2023$440,888
-12.6%
25,633
+2.3%
0.00%
Q4 2022$504,668
-13.9%
25,058
-7.2%
0.00%
Q3 2022$586,000
-11.7%
27,016
+14.4%
0.00%
Q2 2022$664,000
-85.2%
23,625
-75.8%
0.00%
-100.0%
Q1 2022$4,497,000
-75.6%
97,455
-55.5%
0.00%
-75.0%
Q4 2021$18,419,000
+111.3%
219,115
+67.5%
0.00%
+100.0%
Q3 2021$8,718,000
+12.8%
130,812
-9.9%
0.00%0.0%
Q2 2021$7,728,000
-23.6%
145,249
-37.7%
0.00%
-33.3%
Q1 2021$10,110,000
-29.5%
233,007
-15.6%
0.00%
-25.0%
Q4 2020$14,339,000
+60.6%
276,069
+1.1%
0.00%
+33.3%
Q3 2020$8,928,000
-33.0%
273,109
-1.5%
0.00%
-40.0%
Q2 2020$13,320,000277,3930.01%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 1,824,583$39,520,00014.33%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,301,771$49,857,0004.79%
Matrix Capital Management Company, LP 9,199,973$199,271,0003.81%
Integral Health Asset Management, LLC 550,000$11,913,0002.31%
Avidity Partners Management LP 4,223,100$91,472,0001.86%
Affinity Asset Advisors, LLC 170,000$3,682,0001.03%
Eventide Asset Management 1,861,000$40,309,0000.79%
Sofinnova Investments, Inc. 583,357$12,636,0000.74%
Nicholas Investment Partners, LP 158,704$3,438,0000.32%
SECTORAL ASSET MANAGEMENT INC 60,000$1,300,0000.26%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders